Skip to content

LBRX LBRX Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Alkermes logo
AlkermesALKS
$5.89B+9.7%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$862.73M
Alto Neuroscience logo
Alto NeuroscienceANRO
$718.14M+1,128%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$547.19M+35.0%
Opko Health logo
Opko HealthOPK
$865.34M-22.4%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Computed from the period-end share price: $707.12M.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's market capitalization?
LBRX (LBRX) reported market capitalization of $707.12M in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.